CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 456 enrolled
Drug / intervention
Best medical management +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04551664
NCT04551664N/ACompleted

Study of Endovascular Therapy in Acute Anterior Circulation Large Vessel Occlusive Patients With a Large Infarct Core: A Multi-centered, Prospective, Open-label, Blind Endpoint, Randomized Controlled Trial(ANGEL-ASPECT)

Beijing Tiantan Hospital·interventional·Posted Sep 16, 2020·Updated Oct 17, 2023

In Brief

A clinical study evaluating Best medical management and Endovascular therapy for Acute Ischemic Stroke. Completed, enrolled 456 participants across 1 site.

Detailed Summary

Endovascular therapy (EVT) was recommended as the primary treatment for patients with acute large vascular occlusion (LVO) in anterior circulation. However, the evidences of EVT for patients with large infarct volume were limited. In this study, the investigators assume that best medical management plus EVT might be superior than best medical management alone for patients who have evidence of a large infarct volume. The primary objective of the study was to establish the safety and efficacy of EVT in patients presenting with symptoms of acute ischemic stroke (AIS) from LVO in the anterior circulation and having a large infarct volume.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedSep 16, 2020
Enrollment StartOct 2, 2020
Primary CompletionAug 15, 2022
Study CompletionMay 30, 2023
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 5.8 years ago

Interventions

Best medical managementdrug

All the patients enrolled received standard guideline-directed medical therapy including: monitor vital signs, management of blood pressure, glucose and lipids, antithrombotic (antiplatelet or anticoagulant therapy determined by treating physician) therapy if appropriate.

Endovascular therapyprocedure

In the procedure, the methods including mechanical thrombectomy, aspiration thrombectomy, intra-arterial thrombolysis, angioplasty and stenting can be used according to the local interventionalists' choice. Mechanical thrombectomy (recommended with Solitaire、EMBOTRAP、Trevo or Reco revascularization device) or aspiration thrombectomy (recommended with Penumbra) will be recommended as the primary treatment.